SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-24-000127
Filing Date
2024-03-04
Accepted
2024-03-04 16:02:23
Documents
91
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K atxs-20231231x10k.htm   iXBRL 10-K 2245777
2 EX-10.18 atxs-20231231xex10d18.htm EX-10.18 443871
3 EX-10.19 atxs-20231231xex10d19.htm EX-10.19 1617975
4 EX-21.1 atxs-20231231xex21d1.htm EX-21.1 4764
5 EX-23.1 atxs-20231231xex23d1.htm EX-23.1 3327
6 EX-31.1 atxs-20231231xex31d1.htm EX-31.1 10356
7 EX-31.2 atxs-20231231xex31d2.htm EX-31.2 10528
8 EX-32.1 atxs-20231231xex32d1.htm EX-32.1 6067
9 EX-32.2 atxs-20231231xex32d2.htm EX-32.2 6186
10 EX-97.1 atxs-20231231xex97d1.htm EX-97.1 39063
11 GRAPHIC atxs-20231231xex10d19001.jpg GRAPHIC 63175
12 GRAPHIC atxs-20231231xex10d19002.jpg GRAPHIC 147102
13 GRAPHIC atxs-20231231xex10d19003.jpg GRAPHIC 107684
14 GRAPHIC atxs-20231231xex10d19004.jpg GRAPHIC 91584
15 GRAPHIC atxs-20231231xex10d19005.jpg GRAPHIC 165487
16 GRAPHIC atxs-20231231xex10d19006.jpg GRAPHIC 137948
17 GRAPHIC atxs-20231231xex97d1001.jpg GRAPHIC 4695
  Complete submission text file 0001410578-24-000127.txt   11456590

Data Files

Seq Description Document Type Size
18 EX-101.SCH atxs-20231231.xsd EX-101.SCH 49748
19 EX-101.CAL atxs-20231231_cal.xml EX-101.CAL 50266
20 EX-101.DEF atxs-20231231_def.xml EX-101.DEF 222114
21 EX-101.LAB atxs-20231231_lab.xml EX-101.LAB 485546
22 EX-101.PRE atxs-20231231_pre.xml EX-101.PRE 366138
93 EXTRACTED XBRL INSTANCE DOCUMENT atxs-20231231x10k_htm.xml XML 1202721
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37467 | Film No.: 24714923
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)